Insider Transactions Reported by 23 Insiders of Allogene Therapeutics, Inc.

Symbol
ALLO on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

Allogene Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
TPG GP A, LLC 10%+ Owner $59,413,042 12 Jan 2022
M.D. Ph.D. David D. Chang President and CEO, Director $21,788,475 -$262,953 -1.2% 02 Feb 2026
M.D. Arie Belldegrun Director $11,013,263 02 Feb 2026
ERIC THOMAS SCHMIDT Chief Financial Officer $10,559,464 22 Mar 2023
ALISON MOORE Chief Technical Officer $6,298,457 22 Mar 2023
Zachary Roberts EVP of R&D $5,790,072 -$104,169 -1.8% 02 Feb 2026
Rafael Amado EVP of R&D $5,266,179 07 Oct 2022
Veer Bhavnagri General Counsel $4,385,947 14 Mar 2023
Geoffrey M. Parker Chief Financial Officer $3,204,812 -$88,411 -2.7% 02 Feb 2026
Earl Douglas SVP, General Counsel $2,415,932 -$40,304 -1.6% 02 Feb 2026
VICKI L. SATO Director $919,104 18 Jun 2025
Franz B. Humer Director $664,215 18 Jun 2025
YINLIN JACK CHEN SVP, Finance $658,863 10 Aug 2023
Joshua A. Kazam Director $459,499 18 Dec 2025
Lillian Smith VP, Corporate Counsel $445,654 01 Apr 2023
TIMOTHY L. MOORE Chief Technical Officer $428,719 03 Feb 2025
Benjamin Machinas Beneski SVP, Chief Technical Officer $363,597 -$24,857 -6.4% 02 Feb 2026
Annie Yoshiyama SVP, Finance $224,153 -$20,705 -8.5% 02 Feb 2026
DEBORAH M. MESSEMER Director $152,552 -$84,727 -36% 18 Jun 2025
Stephen Mayo Director 18 Jun 2025
OWEN N. WITTE Director 18 Jun 2025
PF Equity Holdings 2 B.V. 10%+ Owner 31 Mar 2022
Elizabeth A. Barrett Director 18 Jun 2025

Recent Insider Transactions by Companies or Individuals for Allogene Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.